- Home
- LRMR vs CAL Comparison
LRMR vs CAL Comparison
Compare LRMR & CAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LRMR | CAL |
|---|---|---|
| Founded | N/A | 1878 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 332.1M | 382.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LRMR | CAL |
|---|---|---|
| Price | $3.41 | $13.54 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 1 |
| Target Price | ★ $16.71 | $14.00 |
| AVG Volume (30 Days) | ★ 1.4M | 1.2M |
| Earning Date | 11-05-2025 | 12-09-2025 |
| Dividend Yield | N/A | ★ 2.03% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.62 |
| Revenue | N/A | ★ $2,702,018,000.00 |
| Revenue This Year | N/A | $1.74 |
| Revenue Next Year | N/A | $5.85 |
| P/E Ratio | ★ N/A | $22.36 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.61 | $9.54 |
| 52 Week High | $5.37 | $25.04 |
Technical Indicators
Market Signals| Indicator | LRMR | CAL |
|---|---|---|
| Relative Strength Index (RSI) | 44.05 | 59.91 |
| Support Level | $3.12 | $11.09 |
| Resistance Level | $4.15 | $13.85 |
| Average True Range (ATR) | 0.27 | 0.78 |
| MACD | 0.02 | 0.13 |
| Stochastic Oscillator | 37.38 | 86.57 |
Price Performance
Historical ComparisonAbout LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About CAL Caleres Inc.
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.